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INTRODUCTION 
 Gastrointestinal tract malignancies constitutes about 27% of total 
cancers and 20% of all cancer deaths worldwide with highest burden of 62% in 
Asia (1)(7).As GIT malignancies are on the rise in developing countries like 
india, it is essential to classify the type with histopathological, 
immunohistochemical molecular genetic features for prognostic significance 
and for giving target based treatment. Our aim of this study is to evaluate the 
expression of immunohistochemical markers P63 and Calponin in the 
gastrointestinal tract malignancies and to correlate it with the histopathological 
features. Immunohistochemistry plays an important role in grading of 
gastrointestinal carcinomas. P63 and calponin are the new markers tried in 
gastrointestinal tract malignancies and the results were promising.  
 P63 is nuclear marker(2), useful in the prognostic evaluation of 
esophageal carcinomas,poorly differentiated gastric carcinomas(90), poorly 
differentiated colorectal carcinomas and anal squamous cell carcinomas. 
Intense positivity (>50% of tumor cells) leads to poor prognosis. 
 Calponin is cytoplasmic staining marker (3)and in some studies it was 
found that its high expression in the colonic tumor blood vessels inhibits 
metastases by contraction of vascular smooth muscle cells.  
 Both these immunohistochemical markers will be helpful as a tool in 
predicting the prognosis of patients with gastrointestinal tract malignancies and 
play a role in targeted therapy in near future. 
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AIMS AND OBJECTIVES 
1.  To correlate the age, sex and anatomical site of distribution of 
gastrointestinal tract malignancies 
2. To study the histopathological features of gastrointestinal tract 
malignancies  
3. To study the role of expression of immunohistochemaical markers P63 
and calponin in gastrointestinal tract malignancies  
4. To correlate the histopathological features with expression of 
immunohistochemical markers P63 and calponin. 
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REVIEW OF LITERATURE 
 Cancer is one of the leading causes of deaths worldwide. The mortality 
due to cancer in India is projected to increase because of population growth, 
lifestyle changes, urbanization, increasing life expectancy and also due to 
industrialization,. The digestive tract is a major site of cancer in humans. There 
are great differences in incidence among the anatomical sites of the 
gastrointestinal tract from the esophagus to the anus. The most prevalent of 
these is gastric cancer in the Eastern world and colorectal cancer in the Western 
world. Approximately 630,000 deaths occur due to colorectal cancer 
worldwide, accounting for 7 – 8% of all cancer deaths. Gastric cancer accounts 
for approximately 800,000 deaths each year worldwide. In India, esophageal 
cancer is highest in northeastern region, for both males and females. Gastric 
cancer is also prominent problem in northeastern and southern states of the 
Indian subcontinent. In India,(4) the Squamous cell carcinoma of the anal canal 
is an under recognized malignancy. 
EPIDEMIOLOGY OF GASTROINTESTINAL TRACT 
MALIGNANCIES  
• Esophageal cancer in India(5)  
 Fourth common cause of cancer related deaths in India. Eighth common 
cause worldwide. Squamous cell carcinoma accounts for 80% but now 
adenocarcinoma on the rise due to changes in the life style. Predisposing 
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factors are tobacco, alcohol & poor nutrition. countries with high HDI  
(Human Developmental Index) are having increased adenocarcinoma 
incidence(6). In U.S adenocarcinoma risk increased to 400% in the past 25 
years. In India with low HDI, squamous cell carcinoma incidence is more, 
accounting for approximately 47,000 new cases detected per year with 
mortality of 42,000 per year in India(7).  
• Gastric cancer(8)  
 Fifth commonest cancer worldwide with male to female incidence of 
2:1.Gastric cancers are mainly divided into cardia & non- cardia cancers. 
Helicobacter pylori plays an important role in non – cardiac cancers, two to 
three fold increased risk compared to non H. pylori. H.pylori plays a role 
mainly in gastric adenocarcinomas due to Cag A, virulence factor.EBV 
association is also found in some of the cases. Predisposing factors are tobacco, 
alcoholic drinks, salted foods, obesity & processed meat. Diet & lifestyle plays 
an important role in gastric cancers. Increased salt intake damages gastric 
mucosa & leads to cell proliferation. Pickled foods, spicy foods, chilly foods, 
increased temperature foods, smoked dried salted foods are some of the 
predisposing factors. Increased incidence in Kashmir due to consumption of 
salted tea was found in one study. Low starch diet, garlic, onion & selenium are 
protective factors. Reheated foods, oils & refrigeration are not risk facors for 
gastric cancer. 
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• Small intestinal cancers(9) 
 The incidence of small intestinal cancers is less compared to colorectal 
malignancies. several mechanisms play a role for this, 1.much quicker transit 
time of food in small intestine compare to large intestine. (increased peristaltic 
ring contractions in small intestine compared to latter) leads to shorter time of 
exposure of mucosa to carcinogens). 2.lower bacterial load in small intestine & 
therefore decreased concentration of potential carcinogens from bile acid 
breakdown(10). 3. High IgA expression in small intestine confers protection 
against lymphoma. 4. Generation of less ROS (reactive oxygen species) in 
small intestine compared to colon(11). Predisposing conditions for small 
intestinal cancers are inflammatory bowel disease (Crohn’s disease and 
ulcerative colitis), celiac disease, familial adenomatous polyposis, Peutz – 
Jeghers syndrome. Associated other malignancies are Hereditary non polyposis 
colorectal cancer(HNPCC)(12). 
• Colorectal cancer(13) 
 It is the third most common cancer in men and second most common 
cancer in women. Colorectal cancer related deaths are estimated to be 
approximately 60800 worldwide accounting for 8 % of all cancer deaths. In 
India, the annual incidence rates for colon cancer and rectal cancer are 4.4 and 
4.1 per 100,000 respectively. In a recent study, they found out that pattern of 
genomic alterations in colon and rectal tissues were similar regardless of origin 
and anatomical location and therefore tumors of colon and rectum can be 
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grouped together. 24 genes were found mutated in addition to genes identified 
priorly (APC, TP53, KRAS, and PIK3CA). The new genes were SOX9, 
FAM123B/WTX, ERBB2 and IGF2(14). 
Risk factors for colorectal cancers  
Divided into genetic and environmental or life style related factors  
Genetic factors  
 Familial adenomatous polyposis (FAP) and its variants (Turcot, Gardner 
and attenuated FAP) and MYH associated polyposis are most common. 
HNPCC/ Lynch syndrome constitutes the non polyposis colonic category. 
  FAP presents as multiple colonic adenomatous polyps in childhood 
transforming into malignancy at an average age of 45 years due to germline 
mutation of of APC gene on chromosome 5. Attenuated FAP has same genetic 
mutation as FAP but characterized by later average age presentation of 
colorectal malignancies and fewer adenomas compared to former(15). 
 Lynch syndrome (HNPCC), an autosomal dominant condition is due to 
defect in one of the MMR(mismatch repair) genes, namely MLH 1, MSH 2, 
HMSH6,or PMS2. Characteristic feature of this is early average age of onset of 
colorectal malignancy and right sided predominant colonic lesions and its 
association with thyroid, breast and gynaecological malignancies(16). 
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Environmental risk factors(17), (18),(19) 
 Older age group and males are having increased risk of colorectal 
cancer. Increased risk was noted among African American population. Long 
term immunosupression, especially after renal transplantation posseses same 
relative risk, but aged 20-30 years older. Some other important risk factors are 
insulin like growth factors (diabetes with insulin resistance), alcohol 
consumption(especially with positive family history),ulcerative colitis, 
processed meat and fresh red meat consumption, Obesity, cigarette 
smoking,Androgen deprivation therapy (orchidectomy),Acromegaly,History of 
cholecystectomy and Ureterocolic anastomosis. 
Other major associations with conflicting evidences  
 Presence of coronary heart disease,decreased fibre and fruit intake, 
history of prostrate cancer radiotherapy, history of treatment for Hodgkin’s 
lymphoma and decreased physical activity. 
• Anal cancer 
Comprises 2.5% of all gastrointestinal malignancies but incidence is on 
the rise for past 30 years(20). Increased incidence is seen in the following - 
females, infection with Human papilloma virus (HPV)(20), infection with 
human immunodeficiency virus, lifetime number of sexual partners, genital 
warts, cigarette smoking, receptive anal intercourse. In these perspective anal 
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canal malignancies were considered similar to genital malignancies rather than 
gastrointestinal tract malignancies. 
 In 1960's, anal malignancies were thought to be due to chronic perianal 
inflammation and treated routinely by abdominoperineal resection warranting a 
permanent colostomy.But now substantial progress has been made in the 
treatment of anal malignancies. Now it has been found out that HPV infection 
is associated in most of the cases and cure of anal malignancy is possible with 
sparing of anal sphincter(21).  
Embryology of the gastrointestinal tract 
 Gut system extends from the buccopharyngeal membrane to the 
cloacalmembrane and is divided into pharyngeal gut, foregut, midgut and 
hindgut. Epithelium of the digestive system originate in the endoderm, while 
the connective tissue, muscular component and peritoneal components 
originate in the mesoderm.(22) 
 Endoderm and ectoderm contact one another in the 2- to 4-week 
embryo. The endoderm, which forms the roof of the yolk sac, gives rise to the 
future gut, creating the majority of the epithelial lining of the GI tract, biliary 
passages, liver, and pancreas.  
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1. Esophageal Development(23) 
 The cranial part of the primitive foregut gives rise to esophagus, 
recognizable at the third week of gestation as an annular constriction located 
between the stomach and pharynx, elongates and grows in a cephalad direction 
becoming tubular. Cephalad parts of both the esophagus and trachea lie within 
a single common tube. Primitive mesenchyme grows into forming septum, 
eventually separating the esophagus and trachea.  
2. Stomach development(24) 
 The stomach develops from a fusiform foregut swelling at 
approximately 4 weeks of gestation. It originates in the neck and descends into 
the abdomen during the next 8 weeks. The enlarging thoracic contents push the 
stomach caudally. The gastric curvature develops during the 6th to 7th fetal 
week. The first differentiated cell type to appear is the mucous neck cell, which 
acts as a progenitor for the other cell types. Gastric glands begin to develop at 
11 to 14 weeks. Parietal cells appear by 9 to 11 weeks. Endocrine cells begin to 
appear at the second week of fetal life; a full spectrum of endocrine cells is 
present by week 11. Mesoderm surrounding the stomach differentiates into the 
gastric connective tissue and the muscularis propria by the end of the second 
fetal month. The muscularis mucosae forms by the 20th week. 
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3. Small intestine development(25) 
 The duodenum distal to the bile duct, and the jejunum, ileum, cecum, 
ascending colon, and proximal one half to two thirds of the transverse colon 
derive from the midgut and are supplied by the superior mesenteric artery. 
Villous formation with mesenchymal infiltration into the villous core begins at 
the ninth gestational week. Between 9 and 10 weeks, the stratified epithelium 
converts to a simple columnar epithelium (13). Villi are long and tapering by 
20 weeks and the muscle coats are obvious at this time. The epithelium finishes 
its morphologic differentiation into enterocytes, goblet cells, endocrine cells, 
and Paneth cells in the 4 to 5 days prior to birth (16). 
4. Colon, rectum and anal canal development(26) 
 Embryologic midgut gives rise to the proximal colon, including the 
cecum, the ascending colon, and the first two thirds of the transverse colon. 
The rest of the colon and rectum derive from the embryologic hindgut.. The 
midgut returns to the abdominal cavity during the third fetal month. The small 
intestine enters the abdomen first, followed by the cecum. During re-entry, the 
gut rotates an additional 180 degrees, so that the cecum comes to lie in the right 
upper quadrant, hindgut develops into the left transverse colon, descending 
colon, sigmoid colon, rectum, and upper anal canal. The distal hindgut enters 
the cloaca, the structure that ultimately forms the anal canal and the urogenital 
structures. 
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Structure of gastrointestinal tract 
Gastrointestinal tract comprises the following structures: 
Esophagus 
Stomach  
Small intestine (duodenum, jejunum and ileum) 
Large intestine (ascending colon, transverse colon, descending colon 
and sigmoid colon) 
Appendix  
Rectum and anal canal. 
Accessory organs of gastrointestinal system are 
Liver and gall bladder 
Pancreas 
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Figure 1. Anatomy of human Gastrointestinal tract 
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Anatomy of gastrointestinal tract  
1. Esophagus (27) 
 Esophagus extends from cricopharyngeus muscle to gastroesophageal 
junction which forms the upper and lower esophageal sphincters respectively. 
It is a round muscular tube measuring 25cm in length. The lower esophageal 
sphincter is about 40 cm from the inscisor teeth. Lymphatics from the upper 
third of esophagus drains into cervical nodes, middle third drains into 
paraesophageal and paratracheal mediastinal nodes, lower third into aorta and 
celiac nodes. 
2. Stomach(28) 
 Grossly, the stomach is divided into five regions : cardia, fundus,corpus 
or body, antrum and pylorus. Lesser curvature forms superomedial margin, 
greater curvature forms the inferolateral margin. Incisura is the notch in lesser 
curvature formed between the junction of corpus and the antrum. Mucosal folds 
present internally forms the rugae  
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3. Small intestine(28) 
 Divided into three parts: duodenum, jejunum and ileum.Duodenum is 
mostly retroperitoneal and fixed part of the small intestine. Duodenojejunal 
junction is marked anatomically by the ligament of treitz (the site at which the 
bowel becomes unfixed). Kerckring folds are transverse mucosal folds present 
internally. Peyers patches are lymphoid follicles present in the terminal ileum 
on its antimesenteric side with its long axes parallel to the bowel. 
4. Large intestine(28) 
 The terminal 1 to 1.5m of the gastrointestinal system is formed by large 
intestine. It is divided into caecum, ascending colon, transverse colon, 
descending colon, sigmoid colon, rectum and anal canal. The junction of 
transverse colon with ascending colon forms the hepatic flexure and the splenic 
flexure is formed by the junction of transverse colon with the descending 
colon. Rectum forms the distal 15cm of the large intestine and it ends in anal 
canal. 
5. Anal canal(28) 
 It extends from the perineal skin to the distal end of rectum measuring 3 
to 4 cm in length. Hilton line or anal verge forms the junction of anal canal and 
perenial skin. The dentate line is located in the center of the anal canal. Anal 
columns of Morgagni is situated just below the dentate line. 
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Figure 2 : Anatomy of the anal canal 
Histology of Gastrointestinal structure (26) 
The gut contains four concentric layers from lumen towards the outer 
aspect  
Mucosa  
Submucosa 
Muscularis propria  
Serosa / adventitia 
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Figure 3: schematic representation of histology of gastrointestinal tract 
a. Esophagus, b. stomach, c. small intestine, and d. large intestine. 
In general, the Gastrointestinal epithelium invaginate to form glands that 
extends into  
Lamina propria (mucosal glands in the stomach) 
Submucosa (submucosal glands in the esophagus/ Brunner’s glands in 
the duodenum) 
Mucosa and submucosa project into the gastrointestinal lumen forming 
plicae/ rugae. 
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• Gastrointestinal epithelium differs in various anatomical sites  
 
 
 
 
 
 
 
 
 
 
Figure : 4 Histology of Gastrointestinal tract epithelium 
A. Squamous epithelium lines the esophagus and anus. 
B.  In stomach, the lining columnar epithelium comprises surface 
epithelium, pits and glands.  
C. In small intestine, the mucosa comprises crypts and villi and intestinal 
epithelial cells.  
D.  Colon contains similar type of cells but it lacks villi.  
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Histology of the gastrointestinal tract  
• Esophagus  
 Is lined by squamous epithelium, except at its distal end. The squamous 
lining of esophagus protects it from damaging effects of undigested food 
particles over its surface. The squamous mucosa contains three components: 
Squamous epithelium, lamina propria, and a thick muscularis mucosae.  
The squamous epithelium consists of nonkeratinizing stratified squamous 
epithelium. In esophagus, epithelial cell renewal takes an average of  
7 days (26). 
- Squamo columnar junction (29) 
 The normal squamocolumnar junction (SCJ) lies at the level of the 
diaphragm. Current criteria for definition of GEJ is of mainly with gross or 
endoscopic junction, the point of flaring of the esophagus, the proximal limit of 
gastric rugal folds and presence of lower esophageal sphincter. So as per above 
criteria the GEJ is proximally displaced above the Z line or squamocolumnar 
junction. Variability in the extent of the cardiac mucosa likely reflects the 
presence of underlying disorders such as GERD or Helicobacter pylori gastritis 
(25) and suggests that the area of the GEJ is a dynamic structure that may 
change over time. 
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• Stomach(26)  
 The epithelial compartments of stomach is divided into three 
components namely gastric pits and surface lining epithelium, mucous neck 
region and glands. The Stomach is divided into cardiac, oxyntic and pyloric 
areas based on glandular components. The 80% of proximal stomach is 
constituted by oxyntic mucosa and it secretes acid and pepsinogen and the 
distal 20% of stomach is constituted by antropyloric mucosa and has mucous 
secreting glands and endocrine cells. The lamina propria contains loose 
connective tissue rich in immunocompetent cells and muscularis mucosae 
Muscularis mucosae contains smooth muscle cells arranged predominantly in 
circular fashion. The Muscularis Propria(26) contains two layers of muscle 
fibres, the inner muscular layer (the circular layer) and the outer muscular 
(longitudinal layer) named due to the arrangement of muscle fibres.. The 
outermost layer is called adventitia or serosa of loose connective tissue 
containing fat, collagen, and elastic tissues.  
• Small intestine(26)  
 In small intestine, the epithelial lining is uniquely suited to the further 
digestion and absorption of nutrients along a gradient from duodenum to the 
ileum. Contains mainly two components, crypts of Lieberkuhn and villi. Villi 
height : crypt is 3:1 in adults and 2:1 in children. The lining epithelium 
contains heteologous population of cells, enterocytes (absorptive cells), goblet 
cells, endocrine cells, tuft cells, cup cells and M cells. The lamina propria 
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forms the mucosal interglandular tissues. It appears as a delicate, loose, 
connective tissue containing lymphocytes, plasma cells, eosinophils, rarely 
neutrophils, and mast cells. Majority of plasma cells secrete IgA. Lamina 
propria also contains large numbers of macrophages, which play important 
roles in mucosal immunity, antigen presentation, elimination of exogenous 
pathologic antigens or organisms, immunoglobulin production, and 
immunoregulation (30). The gut-associated lymphoid tissue (GALT) primarily 
lies within the lamina propria. It is distributed diffusely or appears as solitary or 
aggregated nodules, which in the ileum are called Peyer patches. Larger 
aggregates contain germinal centers.  
• Large intestine(31)  
 Mucosa is smooth and lacks villi. It contains goblet cells, absorptive 
cells, tuft cells, endocrine cells and paneth cells (especiaaly in the caecum), the 
ratio of absorptive cells to goblet cell is 3:1. Goblet cells secretes mucin into 
the lumen. In the cecum and in parts of the colon, the longitudinal muscle is 
extremely attenuated except in the regions where it forms thick cords (i.e., the 
taeniae coli).The musculature also contains the interstitial cells of Cajal (ICCs). 
ICCs act as pacemakers for the GI muscle (13), facilitate active propagation of 
electrical events, and also mediate neurotransmission. Anus(26)  
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• Anus  
 The mucosa is being protected by squamous epithelium from the 
damaging effects of the passage of solid waste. The anal mucosa is divided into 
four zones 1.coloectal zone 2.transitional zone 3.smooth zone and 4.  
Distal zone. 
GASTROINTESTINAL TUMORS 
ESOPHAGEAL TUMORS 
WHO Histologic Classification of Esophageal Tumors(32) 
I. Epithelial tumors 
Benign 
-Squamous cell papilloma 
Malignant 
-Intraepithelial neoplasia 
 Squamous 
 Glandular (adenoma) 
Carcinoma 
1. Squamous cell carcinoma 
 a. Verrucous (squamous) carcinoma 
 b. Basaloid squamous cell carcinoma 
 c. Spindle cell (squamous) carcinoma 
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2. Adenocarcinoma 
3.  Adenosquamous carcinoma 
4. Mucoepidermoid carcinoma 
5. Adenoid cystic carcinoma 
 6. Small cell carcinoma 
7. Carcinoid tumor 
II. Nonepithelial tumors 
Benign Malignant 
Leiomyoma Leiomyosarcoma  
Lipoma 
 
Rhabdomyosarcoma 
Granular cell tumor Kaposi's sarcoma 
 Malignant melanoma 
-Gastrointestinal stromal tumor 
 Benign 
 Uncertain malignant potential 
 Malignant 
 -Others 
-Secondary tumors/ metastatic tumors 
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Esophageal malignancies 
 Squamous cell carcinoma accounts for majority of esophageal 
malignancies and incidence differs worldwide. The risk factors are smoking, 
alcohol abuse, diet, genetic factors and HPV (33). Achalasia cardia (34), tylosis 
Palmaris et plantaris (35), a genetic disorder characterized by hyperkeratosis of 
palms and soles. Peak incidence – 55 to 65 years with M: F ratio of 3-7:1. Most 
common site – middle third of esophagus (60%), compared to lower third 
(30%). Usually presents at advanced stage with poor prognosis. 
• Pathological features 
1. Gross features  
 These tumors can present as irregular deep ulcers with nodularity in the 
margins or exophytic fungating mass or as mural thickenings.submucosal 
infiltration can undermine adjacent normal mucosa leading to luminal 
narrowing similating a benign stricture and this submucosal spread is not seen 
on gross inspection. 
2. Microscopic features  
 Any degree of differentiation can occur. Well differentiated lesions 
exhibits mild nuclear atypia, pleomophism and adundant keratinisation. In 
poorly differentiated tumors keratinisation is sparse with significant cytological 
abnormalities. 
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• Superficial squamous cell carcinoma 
  Confined to mucosa and submucosa irrespective of nodal status(36) 
these cases were first detected in patients who underwent screening for 
esophageal malignancies in Japan and China.In United states and Western 
Europe, it accounts for upto 22% of resected esophageal squamous 
arcinomas(37). Grossly presents as eroded mucosal depressions, thin plaques or 
even sometimes inapparent on gross inspection. Microscopically it consists of 
invasive nests with irregular borders within the lamina propria or submucosa 
with variable tumor differentiation. These are potentially curable and carries 
favourable prognosis with 5 year survival rate of 90%. Intramucosal 
carcinomas have low nodal metastases risk of 5% with 90 to 100% 5yr survival 
rate(38). Lymph node metastases increases to 45% if submucosa is involved 
and the survival rate falls from 85% to 45% with nodal involvement. Treatment 
options are EMR(Endoscopic Mucosal Resection)(39) and ablative procedures 
including photodynamic therapy are providing curative results.(40) 
• Variants of SCC 
Sarcomatoid carcinoma 
Basaloid SCC 
Verrucous SCC  
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1. Sarcomatoid carcinoma  
 Has biphasic microscopic features, having both carcinomatous and 
spindle cell components (41). Current concept is, the spindle cell component 
though mesenchymal in nature is derived from epithelial origin due to 
permanent change in EMT pathway leading to monoclonal tumors, which 
originate by sarcomatous metaplasia of malignant epithelial cells(42). Most 
common location is middle or lower third of esophagus presents usually as 
bulky exophytic masses measuring approximately 6cms in dimension. 
Microscopically, both sarcomatous and carcinomatous elements appear, former 
forms the bulk of tumor having stellate or spindle shaped cells in storiform 
pattern. Giant cells, cartilaginous or osseous differentiation can be 
seen,adenocarcinomatous elements and undifferentiated carcinoma also 
reported.(43). It can be mistaken for primary sarcoma if carcinomatous 
component is not evident. Prognosis is favourable with limited mural invasion. 
2. Basaloid SCC(44) 
 Referred to as adenoid cystic carcinoma in the past behaves in a similar 
manner like elsewhere in the upper aerodigestive tract.. Peak incidence is 6th to 
7th decade with M:F ratio of 3:1.Most common location is middle third of 
esophagus.The specific microscopic features are invasive lobules of basaloid 
cells exhibiting nuclear crowding, pleomorphism, necrosis, peripheral 
palisading and mitoses with foci of squamous differentiation. Clinical features 
are similar to other squamous cell carcinoma. 
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3. Verrucous SCC  
 Peak incidence – 5th to 6th decade with male predominance of 4:1. Most 
common site is middle third of esophagus. It resembles verrucous carcinoma of 
other sites in upper aerodigestive tract. Grossly presents as large exophytic 
mases with papillary fronds covered by well differentiated sqamous epithelium. 
With bland cytologiacal features and mild nuclear atypia, with varying degrees 
of parakeratosis and hyperkeratosis,diagnosis is easily missed in small biopsies 
unless attention is given to size, circumscription and presence of necrosis in 
endoscopy.(45). These tumors have pushing mode of invasion. Clinically these 
tumors behaves as slow growing and locally aggressive with fistulous tract 
formation.(46) 
4. Adenocarcinoma  
 30 to 40% of esophageal carcinomas are adenocarcinomas(47). In 
majority of cases, it arises from Barrett esophagus.Peak incidence is around 
sixth to seventh decade. Persons with Barret’s esophagus posses annual risk of 
0.4% of adenocarcinoma.(48). Predisposing factors are heavy tobacco abuse, 
alcohol abuse and increased BMI..  
Pathologic features 
 Most common site is lower third of esophagus. Grossly presents as 
irregular, flat plaques or depressed lesions or ulcerating, fungating masses. 
Superficial adenocarcinomas may not be evident grossly.(49). Microscopically 
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the histological patterns are similar to gastric adenocarcinomas, Usually 
Barrett’s esophagus is present adjacent to the tumor. Gland formation and 
mucin production are evident often with intestinal metaplasia and less 
commonly diffuse infiltrative signet type of cells were seen. 
• Molecular genetics (11), (12). 
 SCC of esophagus occurs through somatic mutations, epigenetic 
changes in TSG and cell adhesion molecules. Mutations/ over expressions of 
P53present in majority of the cases of SCC. In microspectrophotometric 
determination, it was found that poorly differentiated tumors harbours high 
DNA ploidy. Aneuploid pattern is seen in DNA studies of 75% 0f cases and 
correlates with higher incidence of nodal metestases and higher grade.  
• Prognosis of esophageal malignancies 
 The overall prognosis is very poor with a median survival of < 1year for 
esophageal malignancies. Females have better prognosis compared to males. 
Intramucosal carcinomas and superficial carcinomas were potentially curable. 
bad prognosis is associated with, > 2 lymph nodes involvement, overexpression 
of EGFR(Epidermal growth factor receptor) and P53. 
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GASTRIC TUMORS 
WHO classification(50) 
I.Epithelial tumors 
-Intraepithelial neoplasia—Adenoma 
Carcinoma 
1. Adenocarcinoma 
 - Intestinal type 
 - Diffuse type 
 a. Papillary adenocarcinoma 
 b.Tubular adenocarcinoma 
 c. Mucinous adenocarcinoma 
 d. Signet-ring-cell carcinoma 
2. Adenosquamous carcinoma 
3. Squamous cell carcinoma 
 4. Small cell carcinoma 
 5. Undifferentiated carcinoma 
 6. Carcinoid (well-differentiated endocrine neoplasm) 
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II.Nonepithelial tumors 
Benign Malignant 
Leiomyoma Leiomyosarcoma  
Schwannoma Kaposi's sarcoma 
Granular cell tumor 
 
Lymphomas 
 Marginal zone B-cell 
lymphoma of MALT type 
Mantle cell lymphoma 
Diffuse large B-cell lymphoma 
Glomus tumor  
 
 
Gastrointestinal stromal tumor 
 -Benign 
 -Uncertain malignant potential 
 -Malignant 
Secondary tumors/metastatic tumors 
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Gastric carcinomas 
 Incidence is more common in Japan, Chile and Italy (51) and decreasing 
in countries like England and United States. All gastric malignancies were 
thought to arise from stem /basal cells of foveolae(52). Gastric carcinomas are 
mostly associated with chronic atrophic gastritis (associated with H.Pylori 
infection) and preceded by stages of dysplasia, in situ carcinomas and 
superficial carcinoma.(53). In 90% cases associated with hypochlorhydria and 
increased intragastric pH leads to bacterial overgrowth and conversion of 
dietary nitrate to nitrite and leads to production of N- Nitrosocompounds which 
are carcinogenic (54). Other conditions associated are gastric polyps, Menetrier 
disease, peptic ulcer and gastric stump. EBV association is reported in some 
cases with male predominance(55). 
• Morphology and classification of gastric carcinoma(53) 
Table 1: classification of gastric carcinomas 
1.Bormann, 
1926. 2.Stout, 1953 
3.Lauren, 
1965 4.Ming,1977 
5.Japanese 
society for 
gastric cancer, 
1981 
6.WHO 2000 
TypeI 
(Polypoid) 
Superficial 
spreading  
 
Diffuse  
 
Expanding 
 
Papillary  
 
Already 
enlisted  
Type II 
(Fungating) 
 
Fungating  
 
Intestinal  
 
Infiltrative Tubular  
 
 
Type III 
(ulcerative) 
 
 
Penetrating  
 
  Poorly 
differentiated 
 
 
Type IV 
(infiltrative). 
 
Linitis 
plastica. 
No special 
type 
 
  Mucinous  
 
Signet ring 
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Other types of gastric carcinomas are : 
Tumors with neuroendocrine differentiation. 
Small cell carcinoma. 
Adenosquamous and squamous cell carcinoma. 
Mucinous carcinoma. 
Parietal gland or oncocytic carcinoma. 
Fundic gland carcinoma. 
Lymphoepithelioma like carcinoma, EBV associated (56). 
Sarcomatoid carcinoma. 
Carcinoma with rhabdoid features. 
Micropapillary carcinoma with frequent lymph node metastases 
Acinar cell carcinoma. 
Clear cell (glycogen rich) carcinoma. 
• Pathological features of gastric carcinomas  
1. Two extremes in gross presentation of gastric carcinomas were found, 
one end with  fungating growth growing into the lumen and other with 
deeply invasive, flat, ulcerative lesion extending through the wall of the 
stomach(57). 
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2. Site prelidiction of gastric tumors (58) 
  Anterior wall >posterior wall>lesser curvature>greater curvature. 
 Carcinomas present in fundic regions likely to invade beyond the 
submucosa compared to those present in the pylorus(59). 
 Mostly all belong to adenocarcinoma category with one of the following 
four cell  types, namely intestinal columnar, goblet cell, foveolar and 
mucopeptic(60). 
3. Mainly two categories exist (by Lauren) 
 Intestinal (53%) and diffuse (33%), others are unclassifiable or 
mixed(61). 
• Intestinal type adenocarcinomas 
 Thought to originate from metaplastic epithelium which is supported by 
ancillary studies (immunohistochemical and microscopic features)(62). The 
tumor size is inversely related to degree of differentiation of the tumor(63). 
Well differentiated tumors simulate a complete type of intestinal metaplasia 
with most of the cells are columnar and mucin secreting(64). Poorly 
differentiated tumors predominantly shows solid pattern(28).  
• Diffuse type adenocarcinoma 
 Classically known as linitis plastica, now designated as signet ring or 
 adenocarcinoma. This type predominantly occurs in the young (65).  
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Gross  
 It presents as thickened and rigid stomach wall usually begins in the 
pyloric region leading to pyloric obstruction. Cut sections show submucosal 
fibrosis with either presence or absence of ulceration. Comb like appearance is 
seen due to segmentation of hypertrophied muscle by thin, parallel, grayish 
white longitudinal lines. 
Microscopy  
  Diffuse pattern of growth of malignant cells seen associated with 
extensive fibrosis along with inflammation with involvement of the entire wall. 
In one type called intramucosal carcinoma, mucosal involvement is more 
compared to deeper layers. Gland formation is less with mostly individual 
tumor cell growth. Mucin production is mostly intracellular leading to typical 
signet ring appearance. Extracellular mucin may also be found but if signet ring 
appearance is present, it should be designated as signet ring carcinoma rather 
than mucinous carcinoma. 
•  Early gastric carcinoma  
 Defined as carcinoma involving the mucosa and submucosa and not 
involving the muscularis externa, regardless of the lymph node status. Divided 
further into minute (<5mm) and small (6 to 10mm) in greatest dimensions(51). 
Endoscopic variants are type 1 or protruding, type2 or superficial, type 3 or 
excavated(66). Most commom site is distal third of stomach > cardia. Nodal 
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metastases is 5% in intramucosal tumors and risk increases to 20% if 
submucosal involvement is present(53).  
• Spread and metastases of gastric carcinoma 
 Tumors of proximal stomach invades to esophagus, while distal stomach 
involves duodenum. Hepatoduodenal nodes are involved in tumors of distal 
third of stomach. Serosal spread is common with tumors of infiltrating type. 
Local extension to spleen, colon, pancreas and omentum can occur.Tumor can 
spread to perigastric, periaortic and celiac nodes after invading rich mucosal 
and submucosal Bormann’s lymphatic plexus(67). 
Frequency of metastases 
 Liver>peritoneum>lung>adrenal gland and ovary  
 Krukenberg’s tumor is bilateral ovarian metastases from primary diffuse 
type of gastric carcinoma.  
• Molecular genetics (13) 
 Different pathways exists for intestinal and diffuse type of gastric 
carcinomas. Multistep progression from gastritis to intestinal metaplasia, 
dysplasia and carcinoma where as the latter arises denovo. 
 Gene expression profiling studies found that the diffuse type involves 
altered expression of genes related to cell – matrix interactions and 
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extracellular matrix components while the intestinal type involves genes related 
to enhancement of cell growth(14). 
 In families with hereditary diffuse gastric cancer, mutations of CDH 1 
gene (truncating germline mutations of E- cadherin) were found. Prophylactic 
gastrectomy is advised for these patients because of high penetrant risk and 
usually occult intramucosal type of signet ring carcinoma is found in these 
patients undergoing gastrectomies. Females harbouring these mutation are at 
risk of developing lobular carcinoma of the breast.(15).  
So it is clearly understood that either loss / decreased expression of E – 
Cadherin, which is a componenent of cell adhesion leads to dyscohesive 
manner of growth resulting in diffuse type of gastric carcinomas.(16). 
-In intestinal type of gastric carcinomas 
 Microsatellite instability (MSI) is found in upto 50% of the cases(17) 
and associated with frame shift mutations of TGFβRII, IGFIIR, BAX, MSH 6, 
MSH 3 and E2F4.(18). Also express TP53 mutations and high hTERT 
expression and some cases show strong membrane positivity for HER2 /c- 
EBRB -2 due to amplification of the HER 2 gene. This later feature helps in 
targeted treatment with trastuzumab(19). 
 Hypermethylation of the RUNX3, tumor suppressor gene is also 
implicated in 60% of gastric carcinomas, mostly of intestinal type. 
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 APC gene mutations contribute for 20% of gastric adenocarcinomas in 
contrast to >75% in adenomas or flat dysplasias. It is clearly evident from this 
that APC gene mutations will not play a significant role in progression of 
adenoma to carcinoma.(20). 
• Prognostic factors 
 Overall prognosis of gastric carcinoma is poor with low 5 yr survival 
rate of 15%. The following are adverse prognostic factors :(68) 
1. Age > 70years. 
2. Tumor location (proximal worser than distal) 
3. Lymphovascular invasion. 
4. CEA levels >10ng/ml  
5. CA19 9 levels >37 μg/ml 
 In histopathological variants, intestinal type has better survival rates 
because of its earlier presentation and less advanced disease. When stage for 
stage matching is done between the tumor types, no difference in survival has 
been noted(69).  
SMALL INTESTINAL CARCINOMAS  
 Annually 6000 new cases are detected in the United States per year. The 
median age of presentation being 55 to 67 years(61).Inspite of large surface 
area, incidence is quite low in small intestinal carcinomas compared to large 
intestine, the reasons discussed before.  
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WHO Histologic Classification of Tumors of the Small Intestine 
1. Epithelial tumors 
 Adenoma 
 -Tubular 
 -Villous 
 -Tubulovillous 
 Intraepithelial neoplasia (dysplasia) associated with chronic inflammatory 
diseases 
 -Low-grade glandular intraepithelial neoplasia 
 -High-grade glandular intraepithelial neoplasia 
 Carcinoma 
 - Adenocarcinoma 
 -Mucinous carcinoma 
 -Signet-ring cell carcinoma 
 -Small cell carcinoma 
 -Squamous cell carcinoma 
 -Adenosquamous carcinoma 
 - Undifferentiated carcinoma  
 Carcinoid (well-differentiated endocrine neoplasm) 
 - Gastrin cell tumor, functioning (gastrinoma) or nonfunctioning 
 -Somatostatin cell tumor 
 -EC cell, serotonin-producing neoplasm 
 -L-cell, glucagonlike peptide and PP/PYY-producing tumor 
 -Mixed carcinoid—adenocarcinoma 
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 -Gangliocytic paraganglioma 
2. Nonepithelial tumors 
Benign  Malignant  
Lipoma       Leiomyosarcoma 
Leiomyoma       Angiosarcoma 
 Kaposi sarcoma 
 Gastrointestinal stromal tumor  
Others 
3. Malignant lymphomas 
Immunoproliferative small intestinal disease (includes α-heavy chain disease) 
Western type B-cell lymphoma of MALT 
Mantle cell lymphoma 
Diffuse large B-cell lymphoma 
Burkitt lymphoma 
Burkittlike/atypical Burkitt lymphoma 
T-cell lymphoma 
Enteropathy associated 
Unspecified 
Others 
Secondary tumors/metastatic tumors. 
Polyps of small intestine  
-Hyperplastic polyp (metaplastic) 
 -Peutz-Jeghers polyp 
 -Juvenile polyp 
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• Small intestinal carcinomas  
  Most common type of small intestine carcinoma is adenocarcinoma, 
constituting 40% of malignancies of small intestine. Distribution is more in 
upper portion of small intestine compared to distal portion, 48% in duodenum, 
32% in jejunum and 19% in ileum(70). Compared to large intestine, small 
intestinal adenocarcinomas are 40 to 60 times less and no sex prelidiction is 
seen in the latter(71). 
 Associated with many syndromes (28) 
-Familial Adenomatous Polyposis  
-Hereditary Nonpolyposis Colorectal Carcinoma (Lynch) syndrome 
-Peutz–Jeghers syndrome 
- Recklinghausen disease. 
Brush cytological diagnosis is ameneable for duodenal carcinomas due 
to its papillary configuration(72).  
• Gross features:  
 The small intestinal carcinomas presents as stenosing, ulcerative, flat, 
infiltrative or polypoidal lesions. Distally located tumors presents as napkin 
ring like appearance, leading to stenosis and dilatation of proximal bowel(73). 
Most of the tumors arise from preexisting adenomas, frequently reported as 
adenoma with dysplasia in endoscopic biopsies. 
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• Microscopy 
 Small intestinal carcinomas develop along the same adenoma 
(dysplasia) carcinoma sequence as seen in the colon. Therefore, the lesions 
begin as adenomas (or as areas of dysplasia in Crohn disease) that 
progressively increase in size and eventually develop into metastasizing 
carcinomas. The rich lymphatic system located superficially in small intestine 
makes it to be termed as carcinoma even if lamina propria is invaded by 
neoplastic cells in contrast to tumors involving the colon, where invasion of 
submucosa should be present to designate it as carcinoma due to the deep 
location of lymphatic plexus in the latter.  
Other types of carcinomas are 
 -Small cell (neuroendocrine) tumors. 
 -Adenosquamous carcinoma. 
 -Anaplastic (sarcomatoid) carcinoma. 
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LARGE INTESTINAL CARCINOMAS 
 Prevalence of large intestinal carcinomas are high in north west Europe 
and North America but low in Asian, African countries and South America. 
These are the most curable forms of cancers of the GIT. Increased incidence 
among young blacks is noted. Mean age of presentation is 6th decade with equal 
sex prelidiction. Cancers occuring in young age (<40 yrs) were mostly located 
in distal colon and rectum with aggressive behavior or having one of hereditary 
colorectal cancer syndromes(74). Elderly patients mostly presents with 
medullary type of cancers. 
• Syndromes associated with colorectal cancers  
-Familial Adenomatosis Polyposes (FAP). 
-Hereditary nonpolyposis colorectal cancer syndrome (HNPCC) / Lynch 
syndrome. 
-Torre – Muir syndrome. 
-Familial colorectal carcinoma 
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WHO Histologic Classification of Tumors of the Colon and Rectum 
1.Epithelial tumors 
 Adenoma 
 -Tubular 
 - Villous 
 -Tubulovillous 
 -Serrated 
 Intraepithelial neoplasia (dysplasia) associated with chronic inflammatory 
diseases 
 -Low-grade glandular intraepithelial neoplasia 
 - High-grade glandular intraepithelial neoplasia 
 Carcinoma 
 -Adenocarcinoma 
 -Mucinous carcinoma 
 - Signet-ring cell carcinoma 
 - Small cell carcinoma 
 - Squamous cell carcinoma 
 - Adenosquamous carcinoma 
 -Medullary carcinoma 
 -Undifferentiated carcinoma 
 Carcinoid (well-differentiated endocrine neoplasm) 
 - EC cell, serotonin-producing neoplasm 
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 -L cell, glucagon like peptide and PP/PYY-producing tumor 
 -Others 
 Mixed carcinoid—adenocarcinoma 
 2.Nonepithelial tumors 
 Benign     Malignant  
 Lipoma      -Leiomyosarcoma 
 Leiomyoma      -Angiosarcoma 
       - Kaposi sarcoma             -Malignant 
melanoma 
Malignant lymphoma 
 -Marginal zone B-cell lymphoma of MALT type 
 - Mantle cell lymphoma 
 - Diffuse large B-cell lymphoma 
 - Burkitt lymphoma 
 - Burkitt like/atypical Burkitt lymphoma 
 - Others 
 Secondary tumors 
 Polyps 
- Hyperplastic polyp (metaplastic) 
 -Peutz—Jeghers 
 -Juvenile  
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Figure 5 : schematic representation of Adenoma carcinoma sequence 
Normal epithelium 
 
5q loss or mutation (FAP). 
 
Hyperproliferative epithelium 
   
Early adenoma (DNA hypomethylation). 
 
12p mutation (KRAS). 
 
Intermediate adenoma 
 
18q loss 
 
 
Late adenoma 
 
 
17p loss, TP53 
 
 
Carcinoma 
 
Metastases 
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Gross features of colorectal carcinomas  
 They present as either polypoidal or ulcerative / infiltrative. The 
polypoidal type presents as bulky mass with sharp delineation from the normal 
bowel, where as the latter one as elevated margins with central ulceration. In 
Japanese literature one variant of the latter was termed as flat/depressed 
carcinoma having significant lympho vascular invasion compared to polypoidal 
type(75). These type of carcinomas usually arise denovo rather than malignant 
transformation from an adenoma. 
• Microscopic variants  
 Usual type is well to moderately differentiated adenocarcinoma 
producing mucin,usually elicits an inflammatory response at the edge of the 
tumor.with production of mainly T lymphocytes and eosinophils. The tumor 
may invade through all layers of the bowel involving pericolic fat, perineural 
spaces and veins. Metaplastic bone formation may be seen rarely in the tumor 
stroma.  
Other variants 
1. Mucinous carcinoma(76),(77) 
 Comprises around 15% of colorectal malignancies and usually presents 
at v younger age group. In this type, large lakes of extracellular mucin seen 
admixed with tumor cells. Atleast 50% of tumor should comprise mucinous 
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foci to designate this type. Usually presents at an advanced stage with poor 
prognosis, than conventional adenocarcinoma . 
2. Signet ring carcinoma(linitis plastica type)(53) 
 Rare type associated with extremely poor prognosis. Microscopically the 
accumulation of intracellular mucin pushes the nucleus to one side giving the 
appearance. Primary from the breast and ovary should be ruled out before 
diagnosing primary signet ring carcinoma in the colon.  
3. Serrated adenocarcinoma 
4. Basaloid (cloacogenic) carcinoma 
5. Clear cell carcinoma 
6. Hepatoid adenocarcinoma 
7. Medullary (solid, undifferentiated) adenocarcinoma 
8. Anaplastic (spindle and giant cell, sarcomatoid) carcinoma 
• Staging and grading of colorectal carcinomas: 
1. Dukes system (1937) is directly related with prognosis. 
Stage A – Involving only the wall of the bowel. 
Stage B – Extending through the wall. 
Stage C - Lymph node metastases. 
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Subdivided into C 1- regional nodes involved. 
                C2 - nodes at mesenteric blood vessel ligature. 
Stage D - Distant metastases. 
2. Astler and Coller system (1954)  
Stage A – Tumor limited to mucosa. 
Stage B1 – Involving upto muscularis externa (but not penetrating). 
Stage B2 – Penetrating muscularis externa. 
Stage C1- Limited to bowel wall but with nodal metastases. 
Stage C2 – Extending through bowel wall with nodal metastases. 
Other systems 
3. AJCC System (American Joint Committee on Cancer). 
Jass et al (78) – considering peritumoral lymphocytic infitration and 
tumor growth pattern as indicators for prognosis. 
• Salient clinical features of colorectal cancers 
1. Altered bowel habits (alternating constipation and diarrhea). 
2. Anemia (chronic blood loss). 
3. Left sided colon tumors presents with intestinal obstruction. 
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4. 25% of caecal tumors presents with signs of acute appendicitis. 
• Spread and metastases of colorectal carcinomas: 
Most common sites are lymph nodes and liver. 
 Lymph node metastases occurs in poorly differentiated tumors and 
tumors with highly infiltrative patterns. Average number of nodes to be 
recovered from colorectal carcinoma specimen as recommended by some 
authors is around 15 nodes (79).  
 At National cancer institute of Merlin, by meticulous manual dissection they 
found out an average of 36 nodes per patient in a consecutive study of 50 cases 
of rectal carcinomas. 
 Pericolonic tumor deposits (PTD’s) should be distinguished from lymph 
node metastases. PTD’s may be present in perineural, perivascular or 
intravascular location beyond the muscularis propria (80). These may have 
some impact in TNM staging of colorectal carcinomas. 
 Tumors showing blood vessel invasion are more prone for liver 
metastases. As ovaries were also involved in high proportion of cases, bilateral 
oophorectomy is performed during initial resection of the tumor as a 
prophylactic measure. At many other sites metastases from the colorectal 
carcinoma mimicks primary adenocarcinoma of involved site, for example in 
ovarian metastases, it appears as primary endometrioid (secretory variant) or 
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clear cell variant(81). In prostrate, it appears as primary adenocarcinoma of the 
prostrate. 
Prognosis of colorectal malignancies(82),(83)  
• Age :  
 Two extremes of age, very young and very old age have poor prognosis. 
Age plays an important role in rectal than colon carcinomas. 
• Sex: 
 Females have better outcome compared to males. 
• Serum CEA levels:  
Levels > 5ng/ml associated with bad prognosis. It is considered as an 
independent prognostic factor. 
• Tumor location: 
Left sided tumors will have good prognosis compared to right sided 
tumors. Tumors arising from sigmoid colon and rectum will have bad 
prognosis.  
In one study, they found out that left sided tumors were presenting with 
late recurrances.  
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• Tumor edge: 
Tumors with polypoidal edge will have better prognosis compared to 
one with non-polypoidal edge. 
• Tumor margins and inflammatory reaction 
The presence of inflammatory infiltrates at the tumor interface and 
presence of degenerative changes within the tumor lead to beter prognosis 
compared to those who lack these features. 
• Microscopic type: 
 Medullary type will have good prognosis. Signet ring, anaplastic and 
mucinous type will have bad prognosis. 
Other bad progostc indicators are 
 1. Tumor angiogenesis 
 2.  Mucin related antigens 
 3.  KRAS mutation 
 4.  Perineural invasion  
 5.  Pericolonic tumor deposits 
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• Molecular genetics(21) 
  According to Fearon and Vogelstein, MMR gene is inactivation is 
caused by either somatic mutations or by epigenetic inactivation (MLH 1). The 
mutational inactivation of MMR genes occurs as second hit, who already 
harbours germline mutation. Tumors associated with MSI are poorly 
differentiated or mucinous with prominent host response, circumscribed growth 
pattern and right sided lesions. Tumor infiltrating lymphocytes are best 
predictors of MSI. 
 Oncogenes involved in somatic mutations were KRAS, BRAF,PIK3 and 
CTNNB1(β catenin). In 40% of cases mutations of the RAS is found. 
Tumor suppressor genes involved are TP53,APC,DPC4/SMAD4,DCC 
and MCC. Of these majority of the cases show mutations of TP53. 
ANAL CARCINOMAS  
 More common in middle age group, with female predominance of 5:1. 
Anal carcinomas are highly associated with HPV infection, particularly HPV 
16, detected in 82% of the cases. 
WHO Histologic Classification of Tumors of the Anal Canal 
1. Epithelial tumors 
Intraepithelial neoplasia (dysplasia) 
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Squamous or transitional epithelium 
 - Glandular 
 -Paget disease 
Carcinoma 
-Squamous cell carcinoma 
-Adenocarcinoma 
-Mucinous adenocarcinoma 
-Small cell carcinoma 
-Undifferentiated carcinoma 
Carcinoid tumor 
2. Malignant melanoma 
3. Nonepithelial tumors 
4. Secondary tumors 
 Most of the anal carcinomas are underdiagnosed and eventually leading 
to advanced stage of presentation. Most common clinical presentation is 
bleeding followed by pain. The site of origin of anal carcinomas are divided 
into  
 Upper (colorectal) zone – adeno carcinoma, small cell carcinoma and 
mucinous adenocarcinoma. 
 Middle, Anal Transformation Zone (ATZ) – squamous, basaloid, 
melanoma and mucinous adenocarcinoma. 
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Lowest (squamous) zone - squamous cell carcinoma and melanoma. 
• Gross features  
  Anal carcinomas usually arise from the pectinate line and grows either 
upward into the rectum and surrounding tissues or outward to the perianal 
tissues. 
 Involvement of the perianal skin may be superficial, with only surface 
ulceration and slightly elevated margins. 
• Microscopic features  
(1) Squamous cell carcinoma 
(2) Cloacogenic (transitional, basaloid) 
 Dougherty and Evans (51)have proposed to subdivide them into five 
types: keratinizing, nonkeratinizing, basaloid, with mucous cysts, and 
pseudoadenoid cystic. The last should be distinguished from true adenoid 
cystic carcinoma of salivary gland type, from which it differs at the 
immunohistochemical level. 
 Paget’s disease of the anal canal (84) 
Classified into following two types  
1. Cutaneous type (apocrine). 
2. Endodermal type (adenocarcinoma like)  
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 Apocrine type is purely intraepithelial where as endodermal type is 
associated with invasive rectal adenocarcinoma.  
 Prognosis of Paget’s disease depends on presence or absence of invasive 
component and involvement of inguinal node. 
 Malignant melanoma of the anal canal:(85), (86). 
 The ratio of melanoma: SCC: Adenocarcinoma is 1:8:250 and most 
common in adults. Mostly arises from the pectinate line and grows towards the 
rectal ampulla. Most common symptom is rectal bleeding > mass>pain. 
 Grossly it present as polypoidal mass either single or multiple with 
smooth surface and it mimicks thrombosed hemorrhoids in early stage. 
Microscopically, the tumor is usually pigmented with junctional 
component and also lentigenous appearance in adjacent mucosa similar to 
melanomas in other sites. 
 Prognosis is extremely poor and is related to tumour size and depth of 
invasion. 
Even, rare adenocarcinomas arising in this region will have plenty of 
melanin accumulation in tumor cells due to colonization mechanism as seen in 
breast carcinoma and it should be differentiated from malignant melanoma. 
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Prognosis of anal carcinomas  
Bad prognostic factors 
1. Older age 
2. Proximally located tumors 
3. Tumor stage  
4.  Inguinal node involvement 
5. Microscopic grade 
6. Basaloid type  
• Molecular genetics(22) 
 P53 overexpression is sen in >85% of the cases but TP53 mutation is 
rare. High SOX 2 and low CDX2 expression is seen in anal carcinomas. 
  Loss of heterozygosity at 11q - is early event in anal carcinogenesis. 
 Additional molecular events leading to invasive carcinoma are allelic 
loss at 5q (APC), 17p(TP53), and 18q (DCC). In HIV patients, loss of 11q 
heterozygosity is more common. 
 Aberrant DNA methylation is present in most cases of AIN 2 and AIN 
3, but not in normal mucosa and AIN 1. 
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IMMUNOHISTOCHEMICAL FEATURES OF GASTROINTESTINAL 
TRACT MALIGNANCIES(91) 
Immunohistochemistry Principle  
 Immunohistochemistry (IHC) is a method for detecting antigens or 
haptens in cells of a tissue section by exploiting the principle of antibodies 
binding specifically to antigens in biological tissues. The antibody-antigen 
binding can be visualized in different manners. Enzymes, such as Horseradish 
Peroxidase (HRP) or Alkaline Phosphatase (AP), arecommonly used to 
catalyze a color-producing reaction. 
• Major components in a complete immunohistochemistry experiment: 
1) Primary antibody binds to specific antigen; 
2) The antibody-antigen complex is formed by incubation with a 
secondary, enzyme- conjugated, antibody; 
3) With presence of substrate and chromogen, the enzyme catalyzes to 
generate colored deposits at the sites of antibody-antigen binding. 
 IHC features of Esophageal carcinomas: 
 Immunohistochemical profile of SCC of esophagus is similar to that of 
its skin counterpart: CK7-, CD20-, CK5/6+, CK10+ and CK14+.SCC is always 
positive for p63. Additionally, most cases of esophageal SCC are also positive 
for p53, a finding not seen in normal esophageal mucosa. 
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 Most cases of esophageal adenocarcinoma involve the lower one third of 
the esophagus and show glandular differentiation. These tumors usually 
express CK7, variable CK20, AMACR, and weak focal CDX-2, an 
immunohistochemical pattern similar to that of gastric adenocarcinoma.P16 is 
negative in esophageal adenocarcinoma unlike SCC (26) 
 IHC features of Gastric carcinomas 
 Majority of gastric adenocarcinomas is located in the pylorus and 
antrum (50-60%), followed by the cardia (25%), and the body or fundus (15-
25%) and may be exophytic, flat or ulcerated.  
Table 2. shows Comparison of immunohistochemical  
expression of various IHC markers between adenocarcinomas  
of esophagus & stomach and Barrett’s esophagus. 
 
  Intestinal type GA shows variable expression of CK7, CK20 CDX-2, 
MUC1, and MUC5AC (45-47). Diffuse type of GA usually develops de novo, 
and is not associated with H. pylori induced IM. Over 70% of cases of the 
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diffuse type of GA are positive for CDX-2, CK, HepPar-1 and variable 
expression of, MUC2 and MUC5AC, but negative for MUC1 and E-cadherin 
((48,49). Cases of poorly differentiated adenocarcinoma with prominent 
lymphoplasmacytic stroma may also be positive for EBV(50,51) 
 IHC features of Small intestine carcinomas 
 Small intestinal adenocarcinomas are CK7+ in more than half of all 
cases, unlike  normal small intestinal mucosa which is CK7- 
  Adenocarcinomas of the small bowel are also positive for CK20, CDX-
2, and  villin. 
 IHC features of Colorectal cancer (CRC) 
 CA is characterized by a CK7 negative and CK20 postive 
immunophenotype, and  thus can be differentiated from non-ampullary 
small intestinal adenocarcinomas by  their lack of expression of CK7 and 
positivity for CK20,  
 CDX-2 is a transcription factor involved in the proliferation and 
differentiation of  intestinal epithelial cells, and the incidence of CDX-2 
expression in adenocarcinoma of the gastrointestinal tract increases from 
esophagus to rectum and  in cases where it is positive all tumor cells show a 
strong staining pattern.  
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 IHC features of Anal tumors 
 Paget disease of the anal canal may arise from an underlying anal gland 
adenocarcinoma, adnexal (eccrine gland) adenocarcinoma or an underlying 
visceral malignancy, most commonly acolorectal adenocarcinoma. The use of 
immunohistochemistry can help differentiate these as those arising from anal 
gland adenocarcinoma would be CK7+/CK20+/CDX-2+/GCDFP-15- from 
adnexal adenocarcinoma would be CK7+/CK20-/CDX-2-/GCDFP-15+ and that 
from a colorectal adenocarcinoma would be CK7-/CK20+/CDX-2+/  
GCDFP-15+-  
Table 3 : Expression of various Immunohistochemical markers in 
gastrointestinal tract malignancies 
 
 The immunohistochemical markers p63 and calponin reactivity will be 
assessed by determining the presence and intensity of staining.(90), (91). 
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• P 63: (staining pattern- nuclear) (90). 
 p63 is a member of the p53 gene family. The gene is located on 
chromosome 3q27-29. It encodes at least six different transcripts with 
transactivation (TAp63) or negative effects (DNp63) on the p53 reporter genes, 
resulting in tumour suppressor and oncogenic effects respectively. The p63 
isoforms lack the N-terminal transactivation domain and inhibit p53. In normal 
tissues, expression was restricted to epithelial cells of stratified epithelia, such 
as skin, esophagus, ectocervix, tonsil, and bladder, and to certain 
subpopulations of basal cells in glandular structures of prostate and breast, as 
well as in bronchi4. In the respiratory tract, normal ciliated and goblet cells 
were p63 negative, but reserve cells were p63 positive. In keratinocytes, the 
expressed isoform is ∆Np63, which presumably maintains epithelial cell 
proliferation 
 In response to DNA damage, the expression of wild type p63 protein is 
upregulated and exerts an important role in maintaining the genomic DNA 
integrity by preventing DNA replication, allowing the cell to activate the DNA 
repair machinery. If there is a failure of DNA repair mechanism then p63 
protein induces the cell to undergo apoptosis.  
 If both the copies of p63 protein gene are mutated then the tumor 
suppressor gene p63 lose control over cell replication and DNA repair leading 
to uncontrolled cell proliferation and malignancy. p63 show strong nuclear 
positivity in poorly differentiated carcinomas. 
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• Calponin (Staining Pattern: Cytoplasmic)(91) 
 Calponin is a smooth muscle-specific protein (actin binding protein) 
which binds strongly to actin in a calcium-independent manner and it stabilizes 
the actin filament system. The calponin binds tropomyosin and F-actin and is 
thought to be involved in the regulation of smooth muscle contraction. The 
expression of calponin is restricted to smooth muscle cells and is a marker of 
the differentiated contractile phenotype of developing smooth muscle. Two 
isoforms of calponin exist whose molecular weights are 34kD and 29kD. 
Expression of the 29kD form is primarily restricted to muscle of the urogenital 
tract. The 34kD isoform is expressed in vascular and visceral smooth muscle of 
trachea, jejunum and oesophagus. Immunohistochemical expression is seen in 
parenchymal and vascular smooth muscle. In knock-out experiments, CN 
deficient mice exhibited morphological fragility in tissues, such as blood 
vessels and uterus and peritoneal membranes leading to highly hematogenous 
metasta-sis and peritoneal dissemination of cancer cells. Peritoneal disease was 
later suppressed by treatment with CN, 8whichimplies an importance of CN to 
protect against cancer dissemination via the stabilization of peritoneal 
membranes. 
 It has recently been demonstrated that CN expression isdown-regulated 
in blood vessels in human malignant mela-noma, hepatocellular carcinoma 
(HCC) and renal cellcarcinoma. In HCC, CN expression levels were correlated 
with disease prognosis. 
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 Additionally, Ramaswamy et al. highlighted CN as one of the nine 
down-regulated genes associated with adenocarcinoma metastasis by 
assessment with micro cDNA arrays. Thus, increasing lines of evidence have 
suggested to us that CN expression level in vessels of cancer tissue could be a 
useful diagnostic indicator of cancer metastasis and patient prognosis in 
conjunction with conventional staging procedures.  
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MATERIALS AND METHODS 
• All cases of Gastro-intestinal tract malignancies obtained either as 
biopsy or resected specimens are included in the study group. 
• Back ground details are collected. 
• Most representative blocks are chosen. 
• Three sections are taken one for hematoxylin and eosin stain and other 
for immunohistochemical stains p63 and Calponin  
 STUDY PLACE : 
 Pathology Department, Govt., Chengalpattu medical college, Chengalpattu. 
COLLABORATING DEPARTMENT  
  Govt., Arignar Anna Memorial Cancer Hospital and Research Institute, 
(GAAMCH & RI), Kaarapettai. 
STUDY DESIGN 
 Retrospective and prospective 
PERIOD OF STUDY 
 3 YEARS (JUNE 2014-JUNE 2017) 
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SELECTION OF STUDY POPULATION 
 Cases selected from tumor register of Govt., Chengalpattu medical 
college, chengalpattu and GAAMCH & RI, kaarapettai. 
NUMBER OF CASES PLANNED TO BE STUDIED = 60 
INCLUSION CRITERIA 
Tissue blocks of patients who are diagnosed as having Gastro-intestinal 
tract malignancies. 
EXCLUSION CRITERIA 
 Tissue blocks of known patients of Gastrointestinal tract carcinoma who 
underwent preoperative therapeutic Radiotherapy or Chemotherapy. 
 Patients diagnosed as neuroendocrine tumors and lymphomas. 
 Patients with non- carcinomatous Gastrointestinal lesions.  
HISTOPATHOLOGICAL EXAMINATION 
 Histopathological categorization, pathological staging & grading of 
Gastro-intestinal carcinomas using Hematoxylin & Eosin stained section in 
correlation with Immunohistochemical markers p63 and Calponin: 
Esophageal carcinoma – Grade 1 – 3. 
Gastric carcinoma – Grade 1- 3. 
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Colorectal carcinoma – Grade 1 – 3. 
Anal carcinoma – Grade 1 – 3. 
Nodal status. 
Depth of invasion. 
IMMUNOHISTOCHEMISTRY 
Expression of p63 and calponin in immunohistochemical stained section 
p63 Expression: 
 POSITVE  -  staining of nucleus of tumor cells  
  -  Intense Staining – (>50% of tumor cells positive) Poor 
prognosis.    
  -  Weak staining – (<5% of tumor cells positive) Better 
prognosis.  
NEGATIVE 
Calponin Expression 
 POSITIVE - staining of stromal tumor blood vessels 
-Intense staining – Better prognosis. 
- Week staining – Poor prgnosis. 
NEGATIVE 
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Immunohistochemistry Procedure 
1. 4μ thick sections were cut from formalin fixed paraffin embedded tissue 
samples and transferred to gelatin-chrome alum coated slides.  
2. The slides were incubated at 58ºC for overnight. 
3. The sections were deparaffinized in xylene for 15 minutes x 2 changes. 
4. Rehydrated through descending grades of alcohol as follows absolute 
alcohol x 2 changes 5 minutes each, 90% alcohol x 5 minutes  
 Washed in distilled water 2 changes, 2 minutes each  
5. Heat induced antigen retrieval was done with microwave oven at 150 
degree Celsius with citrate buffer (pH 6.0) for 15 to 20 minutes. 
6. Then cooled for 10 minutes. 
7. Washed in distilled water 2 changes, 2 minutes each. 
8. Washed in TBS for 2 minutes. 
9. Endoperoxidase blocking was done by adding hydrogen peroxide on the 
section and kept for 5 minutes. 
10. Washed in the wash buffer for 2 minutes twice. 
11. Primary antibody P63 / Calponin Mouse monoclonal,(prediluted) was 
added and  kept for 30 minutes in a moist chamber. 
67 
 
12. Then washed in wash buffer 2 minutes 2 times each. 
13. Poly excel target binder reagent was added and kept for 15 minutes. 
14. Washed in two changes of buffer 2 minutes each. 
15. Poly excel HRP (Horse Radish Peroxidase) was added and incubated for 
15 minutes. 
16. Washed with buffer 2 minutes, 2 changes.  
17. Working DAB chromogen (1ml DAB buffer + 1 drop chromogen, mix 
well) was added and kept for 2-5 minutes. 
18. Then washed in distilled water. 
19. Counter stained with hematoxylin for 30 seconds. 
20. The slides were washed in running tap water for 3 minutes.  
21. The slides were air dried, cleared with xylene and mounted with DPX.  
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STASTICAL ANALYSIS 
 The stastical analysis was done. The primary data was entered in MS 
excel sheet and analysed using SPSS 20V. The results were presented in terms 
of tables and graphs. The descriptive statistics frequency and percentages was 
calculated. The association between the categorical variables were analysed by 
Chi square test with 5% level of significance. 
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RESULTS 
 We had studied sixty cases of gastrointestinal carcinomas from June 
2014 to June 2017 and also usefulness of Immunohistochemistry markers p63 
and calponin in these cases. The cases diagnosed as neuroendocrine tumors and 
lymphomas were excluded from the study. 
 Age group  
 Our study included age group of < 30 years of age to >70 years of age. 
Among these age group of patients, most of the patients are in the age group of 
61 – 70 years, constituting 22 cases (35% of total cases). Only 2 cases were 
found in the age group of < 30 years (3.4 % of total cases). 
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Table 4: Age wise distribution of gastrointestinal tract carcinoms. 
Age Frequency Percent 
<30 2 3.4 
31-40 4 6.7 
41-50 8 13 
51-60 20 33.4 
61-70 21 35 
>70 5 8.5 
total 60 100 
Chart 1 : Age wise distribution 
 
 
 
 
 
 
 Gender wise distribution of the cases 
   Among the sixty cases studied, 70% are male patients (42 cases) and 
30% are female patients(18 cases)     
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Table 5: Gender wise distribution of the cases 
Gender Frequency Percent 
Male 42 70 
Female 18 30 
Total 60 100 
Chart 2 : Gender wise distribution 
 
 
 
 
 
 
 Anatomical site wise distribution of cases  
 In our study, the most common site of gastrointestinal tract cancer is 
found to be stomach (antrum) constituting around 22 cases (36.7%). The 
second most commom site being rectum constituting around 16 cases (26.7%). 
Ileum was the least common site of involvement in our study. 
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Table 6: Anatomical site wise distribution of cases 
Site Frequency Percentage 
  Esophagus  2 3.3 
  Stomach  22 36.7 
  Ileum 1 1.7 
  Colon  9 15 
  Rectum  16 26.7 
 Anus  10 16.7 
 Total 60 100 
Chart 3: Anatomical site wise distribution of cases 
 
 
 
 
 
 
 In our study, among these cases 10% of cases (six patients) presented 
with gastric outlet obstruction.  
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 Histopathological diagnosis wise distribution of cases  
 In this study, among the sixty cases, 53 cases are adenocarcinomas 
(88.4%) was found to be most common histopathological diagnosis with one 
case of intestinal type. The least common type was found to be adenosquamous 
and malignant melanoma, each constituting 2 cases (3.3% each). 
Table 7: Histopathological diagnosis wise distribution of cases 
Histo pathological diagnosis Frequency Percent 
 Infiltrating 
adenocarcinoma 
 
 
Conventional  
 
Intestinal type  
 
Mucinous  
 
47 
 
1 
 
5 
 
78.4 
 
1.7 
 
8.3 
 
Adenosquamous carcinoma 2 3.3 
Infiltrating squamous cell 
carcinoma 3 5.0 
Malignant melanoma 2 3.3 
Total 60 100 
 Histopathological grade wise distribution of cases 
   Among those sixty cases, 20 cases were found to be well differentiated 
(28.3%). 22 cases were found to be moderately differentiated (36.7% of the 
total cases).18 cases were found to be poorly differentiated (33.3%). 
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Table 8: Histopathological grade wise distribution of cases 
HPE Frequency Percent 
Well differentiated 20 33.3 
Moderately differentiated 22 36.7 
Poorly differentiated 18 30.0 
Total 60 100 
 
Chart 4: Histopathological grade wise distribution of cases 
 
 
 
 
 
 
IMMUNOHISTOCHEMICAL ANALYSIS AND INTERPRETATION  
 In our study we have analysed the role of expression of 
immunohistochemical markers P63 and Calponin in sixty cases of 
gastrointestinal tract carcinomas.Staning pattern of P63 was based on positivity 
of tumor cells,  
Weak staining – if < 5% of tumor cells shows positivity. 
75 
 
19
41
0
5
10
15
20
25
30
35
40
45
Intense staining Weak staining
Intense staining – if > 50% of tumor cells shows positivity. 
For P63, intense staining pattern is considered as significant  
(poor prognosis). 
 Expression of P 63 
 Among sixty cases, 19 cases show intense staining and remaining 41 
cases show weak staining. 
Chart 5: staining pattern of P 63 
 
 
 
 
 
  
 P63 expression in relation with histopathological grading 
  Among sixty cases, intense staining of P63 was found in 17 cases of 
poorly differentiated carcinomas with a significant ‘P’ value of 0.001. most of 
the well differentiated carcinomas shows weak staining of P63. 
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Table 9: P63 expression in relation with histopathological grading. 
P63 
HPE 
Chi sq 
 staining  
p 
Poor Moderate well Total percentage 
Weak staining 1 20 20 41 
 
47.23 
68.3 
0.001 Intense staining 17 2 0 19  31.7 
Total 18 22 20 60  100 
Chart 6: P63 expression in relation with histopathological grading 
 
 
 
 
 
 
 Comparison of P63 expression with lymph node status 
 Among the sixty cases, lymph node positivity was found in 17 cases, of 
these 17 cases, 12 cases(with <3 positive nodes) showed weak staining of P63 
and remaining 5 cases (>3 positive nodes) showed intense staining of P63. 
Lymph node negativity is seen in 9 cases, in these 8 cases showed weak 
staining of P63. 
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Table 10: P63 expression with lymph node status 
P63 
Lymph node 
Chi sq p NA (not 
available) 
Negative Positive Total 
Weak 
staining 
21 8 5 41 
2.47 0.29 Intense 
staining 
13 1 12 19 
Total 34 9 17 60 
 
Chart 7: P63 expression with lymph node status 
 
 
 
 
 
 
 Expression of calponin  
 Among sixty cases, strong positivity was seen in 37 cases (61.7%) and 
weak staining was seen in 23 cases (38.3%). 
Lymph node 
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Chart 8: Staining pattern of Calponin 
 
 
 
 
 
 
 Calponin expression in relation with histopathologiacal grading 
  Among these sixty cases, strong positivity was found in well 
differentiated carcinomas and weak staining was found in poorly differentiated 
carcinomas. 
Table 11: Calponin expression in relation with histopathologiacal grading 
Calponin 
HPE 
Chi sq 
Staining 
P 
Poor Moderate well Total percentage 
Weak 
Staining 
18 4 1 23 
42.14 
 
38.3 
0.001 Strong 
Positive 
0 18 19 37 
 
61.7 
Total 18 22 20 60 100 
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Chart 9 :Calponin expression in relation with histopathologiacal grading 
 
 
 
 
 
 
 Calponin expression in relation with lymph node status. 
   Among sixty cases, lymph node status was available for 26 cases. 
Lymph node positivity was seen in 17 cases and negative lymph node status 
was seen in 9 cases. Of these 17 cases, Calponin expression showed strong 
positivity in 9 cases and weak staining in 8 cases. In the latter group, all 9 cases 
showed strong positivity. ‘P’ value was found to be significant of < 0.03. 
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Table 12 Calponin expression in relation with lymph node status 
Calponin 
Lymph node Chi 
sq 
p 
NA Negative Positive Total 
Weak 
Staining 
15 0 8 23 
6.62 0.03 Strong 
Positive 
19 9 9 37 
Total 34 9 17 60 
 
Chart 10 : Calponin expression in relation with lymph node status. 
 
 
 
   
 
 
  
Lymph node 
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Table 13: Comparison of staining pattern of p63 with calponin 
P63 
Calponin 
Chi sq p kappa p Weak 
staining 
Strong 
Positive 
Total 
Weak 
staining 
6 35 41 
30.76 0.0001 -0. 597 0.0001 Intense 
staining 
17 2 19 
Total 23 37 60 
    
The staining pattern of p63 and calponin showed negative correlation 
with a negative kappa value with a significant “p” value of 0.0001.  
 
 
     
  
82 
 
COLOR PLATES 
1. Gross photograph of adenocarcinoma of stomach 
    
  
 
 
 
 
 
 
2. Gross photograph of infiltrating adenocarcinoma of stomach 
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3.Gross photograph of Ileocaecal growth in Ileocolectomy specimen 
 
 
 
 
 
 
 
 
4. Gross photograph of adenocarcinoma of rectum 
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H& E images 
5. Well differentiated adenocarcinoma of stomach (10x) 
 
 
 
 
 
    
 
 
6. Mucinous adenocarcinoma of colon (10x) 
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7. Poorly differentiated adenocarcinoma of stomach(10x) 
 
 
 
 
 
 
 
8. Malignant melanoma of anorectum (10x) 
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9. Infiltrating squamous cell carcinoma of esophagus (10x) 
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IMMUNOHISTOCHEMISTRY IMAGES 
 P63  
10. Intense staining of P63 in poorly differentiated gastric carcinoma 
 
 
 
 
 
 
 
11. Weak staining of P63 in well differentiated adenocarcinoma of stomach  
 
 
 
 
 
 
  
88 
 
CALPONIN STAINING 
12. Intense staining of calponin around tumor blood vessels in well 
differentiated adenocarcinoma of colon(40x) 
 
 
 
 
 
 
 
 
 
13. Weak staining of calponin in poorly  
differentiated adenocarcinoma of colon (10x) 
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DISCUSSION 
 Gastrointestinal malignancies are increasing in incidence due to various 
risk factors and life style modifications in our country. Gastrointestinal 
malignancies are seen in wide range of age group but more common in the age 
group of 50-60 years of age. In our study, most common age group was found 
to be in 6th to seventh decade of age group constituting 26 cases (35% of total). 
In a study conducted by Chhand Das et al(87), they found that most common 
age group was 50 – 60 years for gastric malignancies and 60 – 70 years for 
large intestinal carcinomas. In another study conducted by Biren J. Parikh et al 
(88), they found that peak incidence of gastrointestinal malignancies was 
around sixth decade. similar results was observed by Leena devi et al and 
Assem O et al. but the studies conducted by Prabakar et al showed peak 
incidence was around 5th decade.in a study conducted by Kontham Praveen et 
al(89), the most common age group was found to be around sixth to seventh 
decade for all gastrointestinal tract malignancies. 
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Table 14: Comparison of age group with other studies 
Study Most common age group 
Our study 6th to 7th decade 
Chhand Das et al, 6th to 7th decade 
Biren J. Parikh et al, 6th decade 
Prabakar et al 5th decade 
Kontham Praveen et al 6th to seventh decade 
 
 In general, the incidence of gastrointestinal carcinomas found to be 
more in males compared to females, the ratio being 2.5 to 3: 1.In our study, 
male to female ratio was found to be around 2.33:1compared with study 
conducted by Chhand Das et al, they found the male to female ratio was around 
2.46:1, which is similar with our study. In another study conducted by Biren J. 
Parikh et al, it was found to be around 2.03:1 which is less compared to our 
study. Male preponderance was also seen in other studies conducted by 
Prabakar et al, Mohammad et al and Shahid jamal et al. In a study by Kontham 
Praveen et al, male to female ratio was found to be around, 1.04 :1.This clearly 
indicates that incidence of gastrointestinal tract malignancies was found to be 
more in males compared to females. It may be due to the fact that males are 
exposed to more risk factors compared to females. 
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Table 15: comparison of Sex ratio with other studies 
study Male : female 
Present study 2.33:1 
Chhand Das et al 2.46:1 
Biren J. Parikh et al 2.03:1 
Kontham Praveen et al 1.04 :1 
  
 In our study, most common site involved is stomach constituting 22 
cases (36.7% of the total cases). In a study conducted by Chhand Das et al, 
similarly gastric lesions found out to be the most common lesions, constituting 
appromately 50% of total cases and least common site was esophagus 
constituting 2.6% of total cases. Least common site in our study was found to 
be ileum(one case) and esophagus(two cases) constituting 5% of total cases. In 
our study, rectum is the second most common site (16 cases) and colon is the 
third most common site (9 cases). If we take large intestinal carcinomas as a 
whole, combining colon and rectal carcinomas as single entity as colorectal 
carcinomas, then it will become the most common site constituting 25 cases 
(41.7% of total cases). In an another study by Biren J. Parikh et al, the 
commonest site was found to be colorectal carcinomas (38.4%), similarly in the 
studies conducted by shahid Jamal et al and Thomas et al was found to be 
45.23% and 79.67% respectively. In a study by by Kontham Praveen et al, they 
have taken 108 gastrointestinal tract biopsies, the most common lesion in their 
study was large intestinal lesions, constituting 37.22% of the total cases. 
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Table 16: Comparision of most common site of  
involvement with other studies 
Study Most common site 
Present study Gastric carcinomas (36.7%) 
Chhand Das et al, Gastric carcinomas (50%) 
Biren J. Parikh et al Colorectal carcinomas (38.4%) 
Shahid Jamal et al Colorectal carcinomas (45.23%) 
Kontham Praveen et al, Colorectal carcinomas (37.22%) 
  In general, adenocarcinomas are most common histopathological entity 
in gastrointestinal tract malignancies ranging from 70 to 90% of the total 
gastrointestinal tract malignancies. 
 In our study, the most common histopathological diagnosis was found to 
be adenocarcinoma constituting 53 cases (88.4% of the total cases) with one 
case of intestinal type of adenocarcinoma and 5 cases of mucinous 
adenocarcinomas. The least common histopathological diagnosis was found to 
be adenosquamous carcinoma and malignant melanoma, each constituting 
2cases (3.3% of the total cases). The study conducted by Chhand Das et al, the 
most common histopathological diagnosis was found to be adenocarcinomas 
constituting 91.67% which is similar with our study. In their study they had 
included lymphomas and they found that non hodgkins lymphoma is the 
second most common histopathologial diagnosis followed by GIST. In an 
another study conducted by Biren J. Parikh et al, they found that the most 
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common histopathological type was adenocarcinomas constituting 45.68%. 
followed by squamous cell carcinoma constituting around 32.10%. 
Table 17 :Comparison of histopathological type with other studies 
Study Most common histopathological type 
Present study Adenocarcinoma (88.4%)  
Chhand Das et al Adenocarcinoma (91.67%)  
Biren J. Parikh et al Adenocarcinoma (45.68%). 
 
 In general, the most common grade in gastrointestinal malignancies was 
found to be well differentiated. In our study the most common 
histopathological grade was moderately differentiated carcinomas, constituting 
22 cases (36% of the total).In a study conducted by kontham Praveen et al, well 
differentiated carcinomas constitute the most common grade constituting 
around 57.14% of the total cases. 
 In our study, we had evaluated the role and prognostic significance of 
p63 and calponin among those sixty cases. We have described the staining 
pattern of P63 as weak and intense staining depending upon the nuclear 
positivity of tumor cells and we compared the staining pattern with lymph node 
status available among those sixty cases. 
 In our study, P63 staining pattern was correlated with histopathological 
grading among those sixty cases. Out of these sixty cases, 17 cases of poorly 
differentiated carcinomas showed intense staining pattern for P63 and 20 cases 
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of well differentiated carcinomas show weak staining of P63 and revealed a 
statistically significant “P” value of 0.001. These results are compared with 
study by Y.Song et al, it also showed significant “P”value of 0.017.  
 Among the sixty cases, lymph node positivity was found in 17 cases, of 
these 17 cases, 12 cases(< 3 positive lymph nodes) showed weak staining of 
P63 and remaining 5 cases(> 3 positive lymph nodes) showed intense staining 
of P63. Lymph node negativity is seen in 9 cases, in these 8 cases showed weak 
staining of p63 with a “p” value of 0.29 in this study. This clearly shows that 
P63 staining pattern is directly related to the lymph node status. in lymph node 
negative patients, p 63 staining is weak and intense staining is found in poorly 
differentiated carcinomas. In a study conducted by Y.Song et al(90) on 101 
gastric cancer patients. They found out that, there is significant correlation 
exists between p 63 staining pattern and lymph node status similar to our study 
with a “P” value of 0.003. Cases with <3 nodes positive showed weak 
positivity and cases with >3 nodes positive showed strong positivity in their 
study. 
 These findings suggest that expression of immunohistochemical marker 
P63 correlated well with the lymph node status and grade of the 
gastrointeastinal carcinomas. 
 Similarly, the staining pattern of calponin was also studied in our study, 
we found that out of the total sixty cases, intense calponin staining was found 
in 37 cases (61.7%) and weak staining was found in 23 cases (38.3%).  
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When compared with the histopathological grading the “p” value is found to be 
significant with value of  0.01. When compared with the lymph node status, the 
expression of calponin showed intense staining (strongly positive) in all 9 
lymph node status negative patients with a significant “P” value of 0.03. Poorly 
differentiated carcinomas showed weak staining with calponin. This clearly 
shows that the expression of calponin is inversely related to the lymph node 
status and grade of the tumor. In a study conducted by Y. Yanagisawa et al(91), 
they found the expression of calponin and VEGFR (vascular endothelial 
growth factor receptor) in tumor blood vessels of 56 colon cancer patients who 
underwent colectomy. They found that expression of calponin and VEGFR was 
inversely related to tumor angiogenesis, invasion and metastases.  
The downregulation of calponin is correlated well with the upregulation of 
VEGFR in human colon cancer blood vessels. They calculated the CNPV ratio 
(calponin positive vessel ratio),, the CNPV is more for well differentiated 
carcinomas and less for poorly differentiated carcinomas. Also CNPV ratio is 
more for cases with lymph node negative status and less for patients with 
lymph node matastases with a significant “P” value of <0.05. 
 From our study it is clearly shown that the expression of 
immunohistochemical markers P63 and Calponin are inversely related. The 
intense staining of P63 is correlated well with that of weak staining of Calponin 
in poorly differentiated gastrointestinal carcinomas with a significant “P” value 
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when compared, both P63 and Calponin with lymph node status and grade of 
the tumors. 
 Our study also signifies that, mutation of tumor suppressor gene P63 
leads to tumor progression and reduction of calponin around tumor blood 
vessels and formation of immature blood vessels leading to pericyte leakage 
and results in tumor angiogenesis, tumor invasion and metastases.  
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SUMMARY 
 In our study we took 60 cases of gastrointestinal tract malignancies. out 
of these 60 cases 33 cases were biopsies(endoscopic biopsies from esophagus, 
stomach, colon, rectum and anus) from various anatomical sites of carcinomas 
of the gastrointestinal tract and 27 cases were gastrointestinal tract malignancy 
specimens (gastrectomy specimens including partial, distal,subtotal and total 
gastrectomies, colectomy specimens including hemicolectomy, extended 
hemicolectomy and Abdomino perineal resesction(APR)specimens) were 
included in our study. Our study period was from June 2014 to June 2017. In 
our study we excluded accessory organs of gastrointestinal tract, liver and 
pancreas and also appendix as no case of malignancy of appendix was reported 
during our study period. In this study only gastrointestinal tract carcinomas was 
studied and we had excluded other malignancies of gastrointestinal tract like 
lymphomas, sarcomas and Gastrointestinal tract tromal tumors (GIST). 
  Of these sixty cases, 52 cases were from our department and remaining 8 
cases from our collaborating institution, Govt., Arignar Anna Memorial Cancer 
Hospital and Research Institute(GAAMCH&RI). All eight cases were 
specimens received from our collaborating institution after getting proper 
permission from the Director of the Institution, GAAMC&RI and from our 
institutional ethical committee. 
 In our study we found out the significance of age distribution, site 
distribution, gender distribution, lymph node status and expression of 
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immunohistochemical markers p63 and Calponin in our sixty cases and 
compared with other studies done on gastrointestinal tract malignancies. We 
found the following inferences from our study  
 The most common age group affected by gastrointestinal tract 
carcinomas in our study belongs to sixth to seventh decade, constituting 35% of 
the total cases and the least common age group was < 30 years of age 
constituting only 2 cases (only 3.3% of the total cases). Males were more 
affected than females in our study with sex ratio of 2.3:1.  
 The most common anatomical site of gastrointestinal tract involved in 
our study was gastric carcinomas constituting 36.7% followed by rectal 
malignancies constituting 16 % and least common site is ileum and esophagus, 
together constituting only 5% of the total cases studied. If we take colorectal 
carcinomas as single entity then it becomes the most commom site constituting 
41.7% of the cases.  
 In our study, the most common histopathological diagnosis among those 
sixty cases was adenocarcinoma constituting 88% of the total cases. the least 
common was malignant melanoma constituting 3.3 %. In our study, the most 
common grade among those sixty cases was found to be moderately 
differentiated constituting 22 cases (36.7% of total cases). The lymph node 
status was available for 26 cases in our study,of these 17 cases showed lymph 
node metastases and 9 cases showed no evidence of lymph node metastases. In 
this study, the lymph node status correlates well with the histopathological 
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grade of the tumor. Most of the poorly differentiated tumors showed lymph 
node metastases.  
 Immuno histochemical expression of P63 among these 60 cases showed 
intense staining pattern in 19 cases (31.7%) and weak staining pattern on 41 
cases (68.3%). 
 Out of 9 cases of lymph node negative cases, 8 cases showed weak 
staining of P63. among 17 lymph node positive cases, 12 cases showed weak 
staining and 5 cases showed intense staining of P63.  
 The expression of P 63, when correlated with histopathological grade 
was found to be very significant, with a significant “P” value of 0.001.Most of 
the well differentiated tumors showed weak staining of P63.  
 Similarly, the expression of Calponin was strongly positive in 37 cases 
(61.7%) and weakly positive in 23 cases (38.3%). The expression of Calponin, 
when correlated with lymph node status was stastistically significant with a “p” 
value of 0.03. 
 The expression of Calponin is correlated with histopathological grading 
of those 60 cases and it was found to be statistically significant with a “P” 
value of 0.01. The immunohistochemcial expression of Calponin was found to 
be inversely related to the lymph node status and histopathological grading of 
the gastrointestinal tract malignancies studied. 
 In the present study, the expression of p63 is inversely related to 
calponin expression in gastrointestinal tract carcinomas.     
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CONCLUSION 
 In our study we analysed sixty cases of gastrointestinal tract 
malignancies and found the expression of immuno histochemical markers p63 
and calponin in those sixty cases. Increased expression of p63 is directly 
related to the lymph node metastases and the grade of the tumors. while 
calponin expression is inversely related to the grade and lymph node status of 
the cases studied. This study clearly showed that higher expression of calponin 
inhibits tumor metastases, tumor angiogenesis and tumor invasion, especially 
in patients with colorectal carcinomas. So targeted therapy with calponin will 
be prognostically beneficial to the patients with gastrointestinal tract 
carcinomas. Similarly p63 targeted therapy will be beneficial and improves the 
survival rate of the patients with gastrointestinal tract malignancies, especially 
in poorly differentiated esophageal carcinomas, gastric carcinomas and 
colorectal carcinomas.  
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ANNEXURE - I 
PROFORMA 
Date:   
1. Name :      OP/IP No :        
2. Age : 
3. Sex :  Male  Female 
4. History  :  
Histopathological grading  
Histopathological categorization, pathological staging & grading of Gastro-
intestinal carcinomas using Hematoxylin & Eosin stained sections.  
Esophageal carcinoma – Grade 1 – 3. 
Gastric carcinoma – Grade 1- 3. 
Colorectal carcinoma – Grade 1 – 3. 
Anal carcinoma – Grade 1 – 3. 
Nodal status. 
Depth of invasion. 
Expression of p63 and calponin in immunohistochemical stained sections 
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p63 Expression: 
 POSITVE - Intense Staining – (>50% of tumor cells positive) Poor prognosis.    
  - Weak staining – (<5% of tumor cells positive) Better prognosis.  
NEGATIVE 
Calponin Expression 
 POSITIVE - staining of stromal tumor blood vessels 
   -Intense staining – Better prognosis. 
   - Weak staining – Poor prgnosis. 
NEGATIVE 
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ANNEXURE 2 
MASTER CHART KEY 
1. Sex: 
 Male – 1 
 Female -2. 
2. Histopathological diagnosis: 
 Adenocarcinoma -1 
 Adenosquamous carcinoma- 2 
 Squamous cell carcinoma – 3 
 Mucinous carcinoma – 4 
 Malignant melanoma – 5 
 Intestinal type carcinoma – 6 
3. Histopathological grading of tumors: 
 Well differentiated tumors – 1 
 Moderately differentiated tumors – 2 
 Poorly differentiated tumors – 3. 
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4  Immunohistochemical markers staining pattern : 
• P63 stianing pattern- 
 Weak staining – 1 
 Intense staining – 2 
• Calponin staining pattern- 
 Weak staining – 1 
 Strong positive staining – 2 
5. Lymph node status : 
 Positive – 1 
 Negative – 2 
 Not known – 3 
6. Specimen type: 
 Biopsy – 1 
 Colectomy -2 
 Abdominoperenial reection – 3 
 Partial gastrectomy – 4 
 Distal gastrectomy – 5 
 Subtotal gastrectomy - 6 
 Total gastrectomy – 7. 
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ANNEXURE 3 
GLOSSARY 
AIN   :   Anal intraepithelial neoplasisa 
ATZ  :   Anal transformation zone 
CEA   :  Carcino embryonic antigen 
CN : Calponin 
DAB  :  Di amino benzidine 
EBV  :   Ebstein barr virus. 
EMR    :   Endoscopic mucosal resection 
FAP  :   Familial adenomatoses polyposis 
GIT    : Gastrointestinal tract 
GERD :  Gastroesophgeal reflux disease. 
GALT     :  Gut associated lymphoid tissue 
H&E :  Haematoxylin & Eosin 
HNPCC :   Hereditary non polyposis colon cancer 
HDI  :   Human Development Index 
HPV :   Human papilloma virus. 
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ICC  :   Interstitial cells of cajal. 
IHC  : Immunohistochemistry 
PBS :  Phosphate buffer solution 
PTD   : Pericolonic tumor deposits. 
SCJ  :   Squamocolumnar junction. 
TBS :  Tris buffer solution 
WHO :  World Health Organisation 
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1 1664/15 48 2 Anorectum anorectal growth 3 2 1 2 1 3
2 36/16 55 1 Anus anal growth 1 2 1 2 1 3
3 1880/16 58 1 Anus anal growth 3 2 1 1 1 3
4 406/15 55 1 Anus growth anal canal 4 2 1 1 1 3
5 1375/15 70 1 Anus Anal carcinoma 1 1 1 2 1 3
6 548/15 52 1 Anus growth anal canal 5 3 1 1 1 3
7 141 /15 47 1 Anus                                                                anal  polyp Anal polyp 2 2 1 2 1 3
8 133/15 65 2 Anus                                                                growth anal canal anal canal growth 3 2 1 2 1 3
9 1145/15 60 1 Colon carcinoma asc.colon 1 1 1 2 2 1
10 962/17 57 1 Colon carcinoma colon 1 2 1 2 2 2
11 432/17 42 2 Colon - descending colon growth descending colon1 2 2 2 2 2
12 498/17 75 2 Colon - splenic flexure carcinoma splenic flexure1 1 1 2 2 2
13 877/17 54 1 Colon transverse growth transverse colon 1 1 1 2 1 3
14 210/17 40 1 Colon transverse mass transverse colon 1 2 1 2 2 2
15 290/17 60 1 Esophagus carcinoma esophaus 2 3 2 1 1 3
16 1409/15 42 1 Ileum carcinoma intestine 1 2 1 2 1 3
17 233/17 20 1 Ileum intestinal obstruction 1 1 1 2 1 3
18 944/17 55 1 Rectosigmoid region rectosigmoid growth 5 3 1 1 3 1
19 1019/17 57 1 Rectosigmoid region rectosigmoid growth 4 1 1 2 2 2
20 631/k/15 70 1 Rectosigmoid region growth rectosigmoid 1 1 1 2 3 1
21 579/k/16 60 1 Rectosigmoid region carcinoma rectosigmoid 1 1 1 2 3 1
22 632/k/16 42 2 Rectosigmoid region growth rectosigmoid 1 1 1 2 2 1
23 1016/17 70 1 Rectum rectal growth 1 1 1 2 3 2
24 781/15 54 1 Rectum carcinoma rectum 4 2 1 2 3 1
25 46/16 36 1 Rectum carcinoma rectum 1 2 1 1 3 3
26 1842/15 36 1 Rectum carcinoma rectum 1 2 1 2 1 3
27 1866/16 70 1 Rectum growth rectum 1 1 1 2 1 3
28 771/17 55 1 Rectum rectal growth 5 3 1 1 1 3
29 626/16 50 1 Rectum rectal growth 1 2 2 2 1 3
30 45/16 60 2 Rectum rectal growth 1 2 1 2 1 3
31 67/16 80 1 Rectum carcinoma rectum 1 2 1 2 1 3
32 901/k/15 60 1 Rectum carcinoma rectum 1 1 1 2 2 1
33 118/17 68 1 Rectosigmoid rectosigmoid growth 1 1 1 1 2 1
34 1687/16 65 2 Sigmoid colon growth sigmoid colon 1 1 1 2 1 3
35 1685/16 68 1 Sigmoid colon growth sigmoid colon 1 2 1 1 2 1
36 399/17 34 1 Sigmoid colon growth sigmoid colon 1 1 1 2 2 2
37 410/17 60 1 Stomach - body & antrum growth body of stomach 1 3 2 1 1 3
38 1776/15 65 2 Stomach-  body &antrum carcinoma stomach 1 3 2 1 7 1
39 734/15 65 1 Stomach antrum GOO 4 2 1 2 4 1
40 1006/17 70 1 Stomach antrum & pylorusGOO 1 3 2 1 1 3
41 408/17 55 1 Stomach antrum & pylorusantral growth 1 1 1 2 1 3
42 994/17 67 2 Stomach antrum & pylorusantral growth - growth 1 3 2 1 1 3
43 263/k/15 30 2 Stomach antrum & pyloruscarcinoma stomach 1 3 2 1 5 1
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44 96/16 81 1 Stomach antrum & pyloruscarcinoma stomach 1 3 2 1 4 1
45 422/17 68 1 Stomach antrum & pyloruspyloric antrum growth 1 1 1 2 6 2
46 709/k/15 57 2 Stomach antrum & pylorusantral growth 1 1 1 2 6 1
47 1888/15 70 2 Stomach body growth body of growth 1 3 2 1 1 3
48 1378/15 65 1 Stomach body GOO 1 3 2 1 1 3
49 1073/15 76 1 Stomach antrum & pyloruspyloric growth 1 3 2 1 1 3
50 1755/15 67 2 Stomach antrum & pyloruscarcinoma stomach 1 3 2 1 6 1
51 149/16 70 1 Stomach antrum & pylorusantropyloric growth 1 3 2 1 1 3
52 355/16 45 1 Stomach antrum & pyloruspyloric antral ulcer 1 2 1 2 1 3
53 255/15 45 1 Stomach pylorus carcinoma stomach 6 2 1 2 1 3
54 954/17 70 1 Stomach pylorus pyloric growth 1 3 2 1 1 3
55 294/16 77 1 Stomach pylorus GOO 1 2 1 2 1 3
56 36/17 70 1 Stomach pylorus pyloric growth 1 1 1 2 1 3
57 764/16 53 2 Stomach pylorus carcinoma stomach 1 3 2 1 1 3
58 1121/k/16 62 2 Stomach pylorus pyloric growth 1 2 1 2 5 1
59 236/k/15 55 2 Stomach pylorus carcinoma stomach 1 2 1 2 4 2
60 843/16 65 2 Stomach pylorus carcinoma stomach 1 3 2 1 6 1
